Gaik Wei Tew

Title: Gaik Wei Tew: Innovator in Gastrointestinal Disease Treatment

Introduction

Gaik Wei Tew is a prominent inventor based in Belmont, CA (US). He has made significant contributions to the field of medicine, particularly in the diagnosis and treatment of inflammatory bowel diseases. With a total of 5 patents to his name, Tew's work has the potential to impact many lives suffering from gastrointestinal disorders.

Latest Patents

Tew's latest patents focus on methods for diagnosing and treating inflammatory bowel disease. His innovations include biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies. These patents provide methods for using such biomarkers in the treatment of gastrointestinal inflammatory disorders, specifically ulcerative colitis and Crohn's disease. The implications of his work are profound, as they offer new avenues for treatment and management of these challenging conditions.

Career Highlights

Gaik Wei Tew is currently associated with Genentech, Inc., a leading biotechnology company. His role at Genentech allows him to collaborate with other experts in the field and contribute to groundbreaking research. His career is marked by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Tew has worked alongside notable colleagues, including Mary Keir and Jason A Hackney. These collaborations have fostered an environment of innovation and shared knowledge, further enhancing the impact of their collective work.

Conclusion

Gaik Wei Tew's contributions to the field of inflammatory bowel disease treatment exemplify the power of innovation in medicine. His patents and ongoing research continue to pave the way for improved diagnostic and therapeutic strategies.